Cas:39124-27-1 4-amino-1,1-dioxothiane-4-carboxylic acid manufacturer & supplier

Chemical Name:4-amino-1,1-dioxothiane-4-carboxylic acid

CAS.NO:39124-27-1

Synonyms:2H-Thiopyran-4-carboxylic acid, 4-aminotetrahydro-, 1,1-dioxide;4-Amino-1,1-dioxo-tetrahydro-2H-thiopyran-4-carboxylic acid;4-Aminotetrahydro-2H-thiopyran-4-carboxylic acid 1,1-dioxide

Molecular Formula:C₆H₁₁NO₄S

Molecular Weight:193.221

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:483.5±45.0 °C at 760 mmHg

Density:1.5±0.1 g/cm3

Index of Refraction:1.551

PSA:105.84000

Exact Mass:193.040878

LogP:-1.56

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2H-Thiopyran-4-carboxylic acid, 4-aminotetrahydro-, 1,1-dioxide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Aminotetrahydro-2H-thiopyran-4-carboxylic acid 1,1-dioxide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2H-Thiopyran-4-carboxylic acid, 4-aminotetrahydro-, 1,1-dioxide Use and application,2H-Thiopyran-4-carboxylic acid, 4-aminotetrahydro-, 1,1-dioxide technical grade,usp/ep/jp grade.

Related News: RELATED: CVS, Walgreens begin rolling out over-the-counter COVID tests from Abbott, Ellume and more 4-amino-1,1-dioxothiane-4-carboxylic acid manufacturer There were no cases of hospitalization or death among people who received the vaccine, the company reported. Side effects were mild — fatigue, headaches and muscle pain — and reactions tended to be less frequent than those triggered by some already authorized vaccines, the company said. 4-amino-1,1-dioxothiane-4-carboxylic acid supplier From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said. 4-amino-1,1-dioxothiane-4-carboxylic acid vendor There were no cases of hospitalization or death among people who received the vaccine, the company reported. Side effects were mild — fatigue, headaches and muscle pain — and reactions tended to be less frequent than those triggered by some already authorized vaccines, the company said. 4-amino-1,1-dioxothiane-4-carboxylic acid factory There were no cases of hospitalization or death among people who received the vaccine, the company reported. Side effects were mild — fatigue, headaches and muscle pain — and reactions tended to be less frequent than those triggered by some already authorized vaccines, the company said.